| 06:41a | BioNTech Plans 50% Workforce Boost, $57 Million Investment At German Factory | MT |
| 01/25 | Merus Regains Worldwide Rights to MCLA-145 After Incyte Opt-Out; Names Chief Commercial.. | MT |
| 01/25 | NOVARTIS AG : Goldman Sachs gives a Buy rating | MD |
| 01/25 | AlphaValue/Baader Europe Lowers Price Target on Novartis, Upgrades Recommendation to Bu.. | MT |
| 01/24 | NOVARTIS : 2021 Global Managed Access Program Community Update | PU |
| 01/20 | BAUSCH HEALTH BRIEF : He Will join Bausch + Lomb from Allergan/AbbVie; Prior to that, he w.. | MT |
| 01/20 | NOVARTIS AG : JP Morgan keeps a Sell rating | MD |
| 01/20 | "SHOW MORE OF YOU" : Amgen V. Sandoz, Battling It Out On Amgen's Otezla® Drug | AQ |
| 01/18 | Novartis CEO Expects Worldwide Normalcy to COVID-19 By 2022-End | MT |
| 01/18 | GLOBAL MARKETS LIVE : Toyota, Microsoft, Goldman Sachs, Alibaba, Boeing... | |
| 01/18 | Molecular Partners Shares Drop 14% After Novartis Deal | DJ |
| 01/18 | Wall Street Set for Downbeat Open Amid Rising Treasury Yields | MT |
| 01/18 | Health Care Stocks Retreat Pre-Bell Tuesday | MT |
| 01/18 | Top Premarket Decliners | MT |
| 01/18 | Medicenna Therapeutics up 12.7% in US Trade, Details Management Change, Appoints Develo.. | MT |
| 01/18 | Molecular Partners to License Ensovibep to Novartis for COVID-19 | MT |
| 01/18 | Molecular Partners, Novartis Enter Definitive License Deal For COVID-19 Therapy | MT |
| 01/15 | Factbox-GSK's consumer health business | RE |
| 01/14 | NOVARTIS AG : Morgan Stanley gives a Neutral rating | MD |
| 01/12 | Novartis to File for COVID-19 Drug's Emergency Use in US by February Amid Omicron Surge | MT |
| 01/12 | NOVARTIS AG : JP Morgan reiterates its Sell rating | MD |
| 01/11 | Novartis Mulls Oncology, Cardiovascular Treatment Expansion | MT |
| 01/10 | GLOBAL MARKETS LIVE : Meta, Goldman Sachs, Novartis, Tesla, Boeing... | |
| 01/10 | Novartis-Molecular Partners COVID drug could be approved in weeks | RE |
| 01/10 | Molecular Partners Shares Rise 19% After Ensovibep Trial Meets Primary Endpoint | DJ |
| 01/10 | Novartis Still Undecided On Future Of Sandoz | MT |
| 01/10 | Novartis CEO says no decision has been taken on Sandoz | RE |
| 01/10 | Molecular Partners Shares Rise 37% Premarket After Trial Meets Primary Endpoint | DJ |
| 01/10 | EUROPEAN MIDDAY BRIEFING - Stocks Edge Lower, -2- | DJ |
| 01/10 | MARKETSCREENER’S WORLD PRESS REVIEW : January 10, 2022 | |
| 01/10 | Novartis, Molecular Partners Move Forward with COVID-19 Drug After Phase 2 Trial Succes.. | MT |
| 01/10 | Molecular Partners Says Mid-Stage Study of Potential COVID-19 Treatment Meets Primary E.. | MT |
| 01/10 | NOVARTIS : COVID-19 news feed | PU |
| 01/10 | Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners | RE |
| 01/10 | Novartis, Molecular Partners Report Positive Data for Covid-19 Treatment Ensovibep | DJ |
| 01/10 | Novartis, Molecular Partners' COVID-19 Treatment Reduces Viral Load in Mid-Stage Trial | MT |
| 01/10 | Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners | RE |
| 01/10 | Novartis and Molecular Partners Report Positive Topline Data from Phase 2 Study for ens.. | CI |
| 01/07 | NOVARTIS AG : UBS reiterates its Neutral rating | MD |
| 01/06 | Novartis, Alnylam Collaborate on Liver-Targeted Therapy | MT |
| 01/06 | NOVARTIS : announces collaboration with Alnylam to explore targeted therapy to restore liv.. | PU |
| 01/06 | Novartis, Alnylam Pharmaceuticals Partner to Develop Liver-Targeted Therapy | MT |
| 01/05 | Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validit.. | AQ |
| 01/04 | ADRs Close Mostly Higher; Toyota Trades Actively | DJ |
| 01/04 | EUROPEAN MIDDAY BRIEFING - Stocks Gain as -2- | DJ |
| 01/04 | Novartis Says US Appeals Court Upholds Gilenya Dosing Patent | MT |
| 01/04 | NOVARTIS AG : JP Morgan reiterates its Sell rating | MD |
| 01/04 | Novartis Wins US Court Appeal After Challenge to Gilenya Patent | DJ |
| 01/04 | NOVARTIS : announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity.. | PU |
| 01/04 | Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validit.. | DJ |
| 01/03 | Novartis Lands Favorable Ruling From US Court Over Multiple Sclerosis Drug Patent | MT |
| 2021 | The Federal Court Interprets Patent Agent Privilege Provision Of The Patent Act | AQ |
| 2021 | Wolfe Research Lowers Price Target on Novartis, Maintains Outperform Recommendation | MT |
| 2021 | Tech, healthcare stocks lead European shares lower as Omicron cases swell | RE |
| 2021 | UK Clears Novartis' Piqray Drug for Men With Breast Cancer | MT |
| 2021 | Novartis Cosentyx receives FDA approval for the treatment of children and adolescents w.. | AQ |
| 2021 | Sandoz launches authorized generic of Narcan (naloxone hydrochloride) Nasal Spray 4 mg .. | AQ |
| 2021 | NOVARTIS AG : Receives a Buy rating from Jefferies | MD |
| 2021 | NOVARTIS AG : Buy rating from Goldman Sachs | MD |
| 2021 | GLOBAL MARKETS LIVE : Pfizer, Tesla, JD.com, Warner, Cintas... | |
| 2021 | Novartis' Cosentyx Wins US Approval for Use in Children With Certain Types of Arthritis | MT |
| 2021 | Novartis Says FDA Approved Cholesterol Therapy | DJ |
| 2021 | Novartis Wins US FDA Nod For Arthritis Treatment in Children, Adolescents | MT |
| 2021 | Novartis' Bad Cholesterol Reduction Drug Leqvio Gets US FDA Approval | MT |
| 2021 | Novartis Says FDA Approves Cosentyx to Treat Some Children, Adolescents With Arthritis | DJ |
| 2021 | Novartis Cosentyx(R) receives FDA approval for the treatment of children and adolescent.. | DJ |
| 2021 | Novartis Cosentyx® Receives FDA Approval for the Treatment of Children and Adolescents .. | CI |
| 2021 | Novartis Wins US FDA Approval for Leqvio Cholesterol-Reduction Therapy | MT |
| 2021 | Health Care Up As Omicron Seen Spurring Demand For Vaccines, Medications -- Health Care.. | DJ |
| 2021 | FDA Approves Novartis Leqvio, First-In-Class Sirna to Lower Cholesterol and Keep It Low.. | CI |
| 2021 | FDA approves Novartis Leqvio(R) (inclisiran), first-in-class siRNA to lower cholesterol.. | DJ |
| 2021 | FTSE 100 Ends Wednesday Up as UK Traders Appear Cautiously Optimistic | DJ |
| 2021 | ETF PREVIEW : ETFs Mostly Flat, Futures Inch Higher as Wall Street Digests Measures Vs Omi.. | MT |
| 2021 | Omicron Weighs on Already Struggling U.K. Economy | DJ |
| 2021 | EUROPEAN MIDDAY BRIEFING - Shares Little Changed, Appetite Remains Fragile | DJ |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
